The intent of our second Twitter chat on May 17 was to debunk industry claims about the FDA’s device approval process and explain what consumers really need to know about the medical device user fee bills.

The intent of our Twitter chat on May 17 was to debunk industry claims about the FDA’s device approval process and explain what consumers really need to know about the medical device user fee bills.